2004
Polyethylene Glycol 3350 Without Electrolytes for the Treatment of Functional Constipation in Infants and Toddlers
Loening‐Baucke V, Krishna R, Pashankar D. Polyethylene Glycol 3350 Without Electrolytes for the Treatment of Functional Constipation in Infants and Toddlers. Journal Of Pediatric Gastroenterology And Nutrition 2004, 39: 536-539. DOI: 10.1002/j.1536-4801.2004.tb00904.x.Peer-Reviewed Original ResearchTreatment of functional constipationTreatment of constipationFollow-upFunctional constipationPEG therapyLong-term follow-upShort-term follow-upSafety of PEGDuration of constipationRetrospective chart reviewBody weight/dAdverse effectsLong-term dosingPolyethylene glycol 3350Chart reviewDaily treatmentAverage doseHealthy childrenPhysical examinationNo subjectConstipationDosePEG dosesMonthsShort-term
2001
Efficacy and optimal dose of daily polyethylene glycol 3350 for treatment of constipation and encopresis in children
Pashankar D, Bishop W. Efficacy and optimal dose of daily polyethylene glycol 3350 for treatment of constipation and encopresis in children. The Journal Of Pediatrics 2001, 139: 428-432. PMID: 11562624, DOI: 10.1067/mpd.2001.117002.Peer-Reviewed Original ResearchConceptsChronic constipationStool frequencyStool consistencyOptimal dosePolyethylene glycol 3350Weekly stool frequencyTreatment of constipationMean effective doseFisher's exact testSignificant adverse effectsStudent's t-testFecal retentionSoft stoolDaily administrationInitial doseMean doseConstipationExact testEffective doseDoseAdverse effectsT-testChildrenTreatmentEfficacyEfficacy and optimal dose of dally polyethylene glycol 3350 (PEG) for treat of chronic coastipation and encopresis in children
Bishop W, Pashankar D. Efficacy and optimal dose of dally polyethylene glycol 3350 (PEG) for treat of chronic coastipation and encopresis in children. Gastroenterology 2001, 120: a754. DOI: 10.1016/s0016-5085(08)83759-6.Peer-Reviewed Original Research